• Mashup Score: 0

    Digestive Disease Week 2023 in Chicago may have ended in early May, but Healio coverage has continued all month long. Wondering what you missed and what is coming next? Healio recaps the biggest meeting news making waves in the specialty. Healio covered a variety of presentations from this year’s DDW annual meeting, with a significant focus on the latest data on colorectal cancer, including

    Tweet Tweets with this article
    • #DDW23 in Chicago may have ended in early May, but @GoHealio coverage has continued all month long. Wondering what you missed and what is coming next? Healio recaps the biggest meeting news making waves in the specialty. @DDWMeeting #GITwitter https://t.co/wGucTHrgXG https://t.co/m1axbIZK3R

  • Mashup Score: 1

    CHICAGO — The odds of having gastric and pancreatic cancers were higher among postmenopausal women on hormone replacement therapy and remained significant after controlling for risk factors, according to data at Digestive Disease Week.“In the United States, approximately 40% of postmenopausal women use hormone replacement therapy (HRT) — estrogen with or without

    Tweet Tweets with this article
    • The odds of having #gastric and #pancreaticcancers were higher among #postmenopausalwomen on #hormonereplacementtherapy and remained significant after controlling for risk factors, according to data at #DDW23. #GITwitter https://t.co/nsjoQXXzEm

  • Mashup Score: 0

    CHICAGO — In a Healio video exclusive, Claire Jansson-Knodell, MD, shares data that show pregnant women with celiac disease are at greater risk for placental diseases, obstetric complications and having babies small for gestational age.“We wanted to explore pregnancy outcomes using a large database study” Jansson-Knodell, from the department of gastroenterology, hepatology and

    Tweet Tweets with this article
    • In a Healio video exclusive, Claire Jansson-Knodell, MD, shares data that show #pregnantwomen with #celiacdisease are at greater risk for #placentaldiseases, obstetric complications and having babies small for gestational age. #DDW23 #GITwitter https://t.co/OUSRusJylx

  • Mashup Score: 0

    CHICAGO — A large knowledge gap identified between gastroenterologists and primary care physicians in the diagnosis and management of patients with celiac disease highlights the need for further education for general practitioners.“Both gastroenterologists and primary care physicians are responsible for the diagnosis and management of patients with celiac disease,” Niamh Harvey,

    Tweet Tweets with this article
    • #ICYMI from #DDW23: Increased #education for #PCPs could aid early diagnosis of #celiacdisease, improve care #GITwitter #MedTwitter https://t.co/f8qYBqg0Jc https://t.co/9GQ14d3GDS

  • Mashup Score: 0

    CHICAGO — In a Healio video exclusive, Sarah Khan, MD, explains that patients with advanced liver disease and concurrent fungal infection had worse acute-on-chronic liver failure and higher mortality than those with bacterial infection. With limited data on the epidemiology, baseline comorbidities and outcomes of fungal infection in acute-on-chronic liver failure, Khan and colleagues at the

    Tweet Tweets with this article
    • #ICYMI from #DDW23: Severe #ACLF, worse #survival in patients with #liverdisease and #fungalinfection #GITwitter #MedTwitter https://t.co/t6xWNIGxoQ

  • Mashup Score: 0

    CHICAGO — Subcutaneous maintenance therapy with an infliximab biosimilar after IV induction resulted in sustained clinical remission and greater endoscopic response vs. placebo in patients with moderate to severe Crohn’s disease. “In the past several years, there have been a number of formulations of infliximab that have met criteria for what is known as biosimilarity,”

    Tweet Tweets with this article
    • According to @NMH_SHanauerMD, more than 60% of #Crohn’ patients sustained remission with subcutaneous biosimilar CT-P13 #DDW23 #GITwitter https://t.co/SYpUQSAKf5

  • Mashup Score: 0

    CHICAGO — A large knowledge gap identified between gastroenterologists and primary care physicians in the diagnosis and management of patients with celiac disease highlights the need for further education for general practitioners.“Both gastroenterologists and primary care physicians are responsible for the diagnosis and management of patients with celiac disease,” Niamh Harvey,

    Tweet Tweets with this article
    • A large knowledge gap identified between #gastroenterologists and #primarycarephysicians in the diagnosis and management of patients with #celiacdisease highlights the need for further education for general practitioners. #DDW23 #GITwitter https://t.co/f8qYBqg0Jc https://t.co/LUWlRxp1Pl

  • Mashup Score: 0

    CHICAGO — Patients with celiac disease reported various challenges when dating, notably communicating their needs and managing feelings of sadness, anxiety and embarrassment, according to data at Digestive Disease Week.“We already know that that the only treatment for celiac disease is lifelong adherence to a gluten-free diet and many studies have shown the negative impact the diet,

    Tweet Tweets with this article
    • #Patients with #celiacdisease reported various challenges when #dating, notably communicating their needs and managing feelings of #sadness, #anxiety and #embarrassment, @gfree_rd reported at #DDW23. #GITwitter https://t.co/McTPsky4ga https://t.co/PARd3AO2UK

  • Mashup Score: 0

    CHICAGO — In a Healio video exclusive, Sarah Khan, MD, explains that patients with advanced liver disease and concurrent fungal infection had worse acute-on-chronic liver failure and higher mortality than those with bacterial infection. With limited data on the epidemiology, baseline comorbidities and outcomes of fungal infection in acute-on-chronic liver failure, Khan and colleagues at the

    Tweet Tweets with this article
    • In a @GoHealio #GI video exclusive, Sarah Khan, MD, explains that patients with advanced #liverdisease and concurrent #fungalinfection had worse acute-on-chronic #liverfailure and higher mortality than those with bacterial infection. #DDW23 #GITwitter https://t.co/t6xWNIGxoQ

  • Mashup Score: 2

    CHICAGO — Subcutaneous maintenance therapy with an infliximab biosimilar after IV induction resulted in sustained clinical remission and greater endoscopic response vs. placebo in patients with moderate to severe Crohn’s disease. “In the past several years, there have been a number of formulations of infliximab that have met criteria for what is known as biosimilarity,”

    Tweet Tweets with this article
    • Subcutaneous maintenance therapy with an #infliximab biosimilar after IV induction resulted in sustained clinical remission and greater endoscopic response vs. placebo in patients with moderate to severe #Crohnsdisease. #DDW23 @NMH_SHanauerMD https://t.co/SYpUQSBi4D